Differential requirement for p21ras activation in the metabolic signaling by insulin

Area of Science:

• Cellular and Molecular Biology
• Metabolic Signaling
• Insulin Resistance

Background:

• The Ras pathway is crucial for cellular signaling.
• Insulin's metabolic effects are complex and involve multiple pathways.
• Understanding insulin signaling is key to addressing metabolic disorders.

Purpose of the Study:

• To investigate the role of the Ras pathway in insulin's metabolic signaling.
• To determine if Ras pathway activation is necessary for insulin's effects on glucose metabolism and cell proliferation.

Main Methods:

• Utilized lovastatin to inhibit Ras protein isoprenylation in HIRc cells and 3T3-L1 adipocytes.
• Assessed insulin-stimulated activation of p21ras and mitogen-activated protein kinase.
• Measured insulin's effects on thymidine incorporation, glucose incorporation into glycogen, and glucose uptake.

Main Results:

• Lovastatin inhibited insulin's activation of p21ras and mitogen-activated protein kinase.
• Insulin-stimulated thymidine and glucose incorporation into glycogen were significantly reduced by lovastatin.
• Insulin's effect on glucose uptake remained unaffected by lovastatin treatment.

Conclusions:

• Ras pathway activation is essential for insulin's mitogenic actions and glycogenesis.
• Insulin-mediated glucose uptake is independent of Ras pathway activation.
• This suggests distinct signaling mechanisms for different insulin effects.